| Name | Title | Contact Details |
|---|
Weatherwise Usa, Inc is a Pittsburgh, PA-based company in the Business Services sector.
I2X Technologies, also known as ISYS Incorporated, is a 100% women-owned small business based in Littleton, Colorado. With over 20 years of experience, the company provides technology and engineering services primarily to the Department of Defense and federal government agencies. Founded in 1989, I2X Technologies has built a strong reputation as a reliable government services provider, supporting programs across more than 20 states. The company specializes in cybersecurity management, space exploration support, and national security initiatives. I2X Technologies collaborates closely with federal customers and industry partners to deliver tailored technology services that meet the unique needs of defense and space programs. With a workforce of approximately 242 employees, the company fosters a culture of empowerment and engagement, emphasizing employee input and a flat organizational structure.
MeritDirect is one of the leading companies in Business Services industry. MeritDirect is based in Rye Brook, NY. You can find more information on MeritDirect at www.meritdirect.com
At enGene, we are at the vanguard of a new era in genetic medicine: Our novel Dually Derivatized Oligochitosan® (DDX) gene delivery platform is designed to enable localized delivery of multiple gene cargos, including RNA and DNA, directly to mucosal tissues and other organs — potentially overcoming the limitations of viral-based gene therapies and advancing gene therapy beyond rare genetic diseases into the mainstream of clinical practice. Our breakthrough Dually Derivatized Oligochitosan® (DDX) platform opens possibilities for streamlining the use of genetic medicines in the treatment of serious diseases, especially diseases afflicting mucosal tissues. Our lead product candidate, EG-70 (detalimogene voraplasmid), is a non-viral immunotherapy in development to treat non-muscle invasive bladder cancer (NMIBC), a disease with a significant patient burden, high clinical needs, and massive healthcare system economic impact. Based on its preliminary efficacy and safety profile and ease of administration by urologists, EG-70, which is currently in a pivotal trial, can potentially benefit patients across a wide variety of clinical settings. As enGeneers, we are boldly focused on patients needs. We are a team of passionate experts with extensive experience in drug development and commercialization across oncology, respiratory, and several other therapeutic areas. Nasdaq: ENGN
Tampa Brass and Aluminum Corp is a Tampa, FL-based company in the Business Services sector.